相关临床试验
185
60 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1986
进行中（未招募）
15
8.1%
已完成
76
41.1%
尚未招募
45
24.3%
招募中
43
23.2%
终止
2
1.1%
撤回
4
2.2%
暂无批准数据
- Western Australia's Cook Labor Government and The Hospital Research Foundation Group have awarded $775,000 to 15 precision medicine research projects across the state. - Four researchers received Tier One grants of $125,000 over two years, while 11 projects received Tier Two grants of $25,000 over one year. - Funded work targets cancer, dementia, cardiovascular disease, stroke and mental health, including a precision nasal spray for Alzheimer's disease. - The competitive grant round marks the third major collaboration between The Hospital Research Foundation Group and the FHRI Fund in the past 12 months.
- The RESTORE trial demonstrates that cognitive functional therapy (CFT) produces clinically important reductions in chronic low back pain and activity limitations that persist for three years. - CFT, delivered through seven sessions by specially trained physiotherapists, significantly outperformed usual care in reducing both pain intensity and physical activity limitations. - This represents the first large, high-quality study investigating long-term CFT outcomes, offering potential to markedly reduce the global burden of chronic back pain. - The biopsychosocial approach addresses physical, psychological and social factors while empowering patients with self-management skills and confidence to move.
- New research reveals mothers who use cannabis during pregnancy are 3.5 times more likely to have children with disruptive behavioral disorders, including hostility and aggression. - Cannabis compounds can cross the placenta and enter breast milk, potentially affecting fetal brain development and leading to long-term cognitive and behavioral consequences. - The findings align with previous studies, including a 2024 report linking prenatal cannabis exposure to poorer thinking skills, impulse control issues, and attention problems in early childhood.
